Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma

Medical and Pediatric Oncology

Volumn 36, Issue 1, 2001, Pages 75-79

  Wimmer, K ^a,b   Zhu, X X ^a   Lamb, B J ^a   Kuick, R ^a   Ambros, P ^c   Kovar, H ^c   Thoraval, D ^a,e   Elkahloun, A ^d   Meltzer, P ^d   Hanash, S M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^d National Human Genomics Research Institute   (United States)

^e Institut de Biochimie et Genetique Cellulaires   (France)

Author keywords

Gene amplification; MYCN amplicon; Neuroblastoma

Indexed keywords

CHROMOSOME 2; CONFERENCE PAPER; CONTROLLED STUDY; CPG ISLAND; ELECTROPHORESIS; GENE AMPLIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTRON; MOLECULAR CLONING; NEUROBLASTOMA; PRIORITY JOURNAL; RESTRICTION FRAGMENT; SEQUENCE HOMOLOGY;

CHROMOSOMES, HUMAN, PAIR 1; CLONING, MOLECULAR; CPG ISLANDS; DNA, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE AMPLIFICATION; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEUROBLASTOMA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUMOR CELLS, CULTURED;

EID: 0035161668     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20010101)36:1<75::AID-MPO1018>3.0.CO;2-O     Document Type: Article

References (23)

1. Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer
2. MYCN oncogene amplification: A consequence of genomic instability in human neuroblastoma
3. Autoregulation of the human N-myc oncogehe is disrupted in amplified but not single-copy neuroblastoma cell lines
4. Localized resectable neuroblastoma: Results of the second study of the Italian Cooperative Group for Neuroblastoma
5. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells
6. Immunohistochemical analysis of N-myc protein expression in neuroblastoma: Correlation with prognosis of patients
7. N-myc oncogene RNA expression in neuroblastoma
8. myc gene amplification and expression in primary human neuroblastoma
9. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan- and a DEAD box gene, DDX1, with N-myc in neuroblastoma
10. Co-amplification of MYCN and a DEAD box gene (DDXI) in primary neuroblastoma
11. A methylated human 9 kb repetitive sequence on acrocentric chromosomes is homologous to a subtelomeric repeat in chimpanzees
12. Identification of amplifications, deletions, and methylation changes in cancer by means of two-dimensional analysis of genomic digests: Application to neuroblastoma
13. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma
14. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture
15. Definition of a continuous human cell line derived from neuroblastoma
16. Characterization of human neuroblastoma cell lines established before and after therapy
17. A reciprocal translocation (1;15)(36.2;q24) in a neuroblastoma cell line is accompanied by DNA duplication and may signal the site of a putative tumor suppressor-gene
18. Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation - Sign of tumour cell revertance?
19. Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP
20. Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomas
21. Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture
22. Targeted expression of MYCN causes neuroblastoma in transgenic mice
23. Demethylation of repetitive DNA sequences in neuroblastoma